Refeyn

Refeyn is a biotech company in Oxford, United Kingdom, founded in 2018.

Accelerating discovery and revolutionizing single-molecule bioanalytics

Headquarters
Oxford
Employees
51–200
Founded
2018
Business Model
B2B
Website
refeyn.com

About

Refeyn is an Oxford University spinout founded in 2018 that develops and commercializes mass photometry instruments for single-molecule bioanalysis. Its instruments enable researchers to rapidly measure the mass of individual biomolecules — including proteins, antibodies, nucleic acids, and viral vectors such as AAVs — in their native solution state without labels. Refeyn's product portfolio includes the TwoMP, MyMassMP, SamuxMP, and KaritroMP mass photometers, serving pharmaceutical, biotech, and academic research customers globally in drug development, structural biology, and cell and gene therapy quality control.

Summary

It lists 51–200 employees.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Refeyn on Indexed.vc
<a href="https://indexed.vc/companies/refeyn"><img src="https://indexed.vc/api/badge/company/refeyn" alt="Refeyn on Indexed.vc" width="260" height="76" /></a>